Patents by Inventor Soeren Soendergaarad Frederiksen

Soeren Soendergaarad Frederiksen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9447163
    Abstract: The present application discloses a chromatographic process for separating protein components of a protein-containing solution, the solution comprising an insulin peptide and one or more di- or polyvalent metal ions, the insulin peptide being capable of self-association and/or structural change in the presence of di- or polyvalent metal ions, the process comprising the steps of: a) applying the protein-containing solution to a column of a chromatographic solid phase material, wherein the loading of the insulin peptide is at least 6.0 g per liter of column volume (g/LCV); and b) eluting the insulin peptide from the solid phase material using an eluent having a pH of at the most 8.5; and collecting a pool of the insulin peptide corresponding to at least 75% by weight of the insulin peptide applied to the column in step (a).
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: September 20, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Joergen M. Mollerup, Soeren Soendergaarad Frederiksen
  • Publication number: 20140073759
    Abstract: The present application discloses a chromatographic process for separating protein components of a protein-containing solution, said solution comprising an insulin peptide and one or more di- or polyvalent metal ions, said insulin peptide being capable of self-association and/or structural change in the presence of di- or polyvalent metal ions, said process comprising the steps of: a) applying the protein-containing solution to a column of a chromatographic solid phase material, wherein the loading of the insulin peptide is at least 6.0 g per litre of column volume (g/Lcv); and b) eluting the insulin peptide from said solid phase material by means of an eluent having a pH of at the most 8.5; and collecting a pool of the insulin peptide corresponding to at least 75% by weight of the insulin peptide applied to the column in step (a).
    Type: Application
    Filed: February 1, 2012
    Publication date: March 13, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Joergen M. Mollerup, Soeren Soendergaarad Frederiksen